Literature DB >> 19330525

Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database.

Louise A Brinton1, J Daniel Carreon, Gretchen L Gierach, Katherine A McGlynn, Gloria Gridley.   

Abstract

The etiology of male breast cancer is largely unknown, reflecting its relative rarity. Although a number of previous studies have suggested relationships with a variety of medical conditions, the results have largely derived from case-control studies and may reflect recall biases. Within the large U.S. Veterans Affairs computerized medical care system database, we had the opportunity to access 26 million hospital discharge records over the period 1969-1996 and to relate various documented medical conditions to the risk of subsequent male breast cancer. This allowed us to calculate relative risks (RR) and 95% confidence intervals (CI) for male breast cancer associated with conditions occurring one or more years after initial hospitalization, adjusted for age, race, calendar year, duration of follow-up, and number of hospital visits. Among 4,501,578 men aged 18-100 years, a total of 642 cases of primary male breast cancer were identified (523 among whites, 119 among blacks). Medical conditions that were significantly related to risk were diabetes (RR 1.30, 95% CI 1.05-1.60), obesity (1.98, 1.55-2.54), orchitis/epididymitis (1.84, 1.10-3.08), Klinefelter syndrome (29.64, 12.26-71.68), and gynecomastia (5.86, 3.74-9.17). Additionally, among black patients, cholelithiasis emerged as a significant risk predictor (3.45, 1.59-7.47). Diseases that have previously been related to male breast cancer risk that were not supported by our study results included thyroid diseases, smoking-related conditions, liver cirrhosis, prostatic hyperplasia, and fractures. After adjustment for obesity, the association with diabetes disappeared, but that with gynecomastia persisted. In multivariate models that simultaneously considered all important medical predictors of risk, significant risks were seen for Klinefelter syndrome (16.83, 6.81-41.62), gynecomastia (5.08, 3.21-8.03), obesity (1.91, 1.50-2.44), and orchitis/epididymitis (1.80, 1.08-3.01). These results support previous speculations that male breast cancer is influenced not only by tissue at risk, but also by hormonal and inflammatory factors.

Entities:  

Mesh:

Year:  2009        PMID: 19330525      PMCID: PMC2807736          DOI: 10.1007/s10549-009-0379-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  42 in total

1.  Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996.

Authors:  P E Goss; C Reid; M Pintilie; R Lim; N Miller
Journal:  Cancer       Date:  1999-02-01       Impact factor: 6.860

2.  Breast cancer risk in male alcoholics in Sweden.

Authors:  E Weiderpass; W Ye; H O Adami; H Vainio; D Trichopoulos; O Nyrén
Journal:  Cancer Causes Control       Date:  2001-09       Impact factor: 2.506

Review 3.  Testosterone, body composition and aging.

Authors:  A Vermeulen; S Goemaere; J M Kaufman
Journal:  J Endocrinol Invest       Date:  1999       Impact factor: 4.256

4.  The relationship between diet and breast cancer in men (United States).

Authors:  K A Rosenblatt; D B Thomas; L M Jimenez; B Fish; A McTiernan; H Stalsberg; A Stemhagen; W D Thompson; M G Curnen; W Satariano; D F Austin; R S Greenberg; C Key; L N Kolonel; D W West
Journal:  Cancer Causes Control       Date:  1999-04       Impact factor: 2.506

5.  Risk factors for male breast cancer--a case-control study from Scandinavia.

Authors:  M Ewertz; L Holmberg; S Tretli; B V Pedersen; A Kristensen
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

6.  Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.

Authors:  A H Wu; A S Whittemore; L N Kolonel; E M John; R P Gallagher; D W West; J Hankin; C Z Teh; D M Dreon; R S Paffenbarger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995 Oct-Nov       Impact factor: 4.254

7.  Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study.

Authors:  Anthony J Swerdlow; Minouk J Schoemaker; Craig D Higgins; Alan F Wright; Patricia A Jacobs
Journal:  J Natl Cancer Inst       Date:  2005-08-17       Impact factor: 13.506

8.  Risk factors for male breast cancer.

Authors:  K Mabuchi; D S Bross; I I Kessler
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

9.  Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening.

Authors:  U J Lee; J S Jones
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-05-27       Impact factor: 5.554

10.  Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece.

Authors:  E Petridou; G Giokas; H Kuper; L A Mucci; D Trichopoulos
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

View more
  25 in total

1.  Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients.

Authors:  Samuel F Gilbert; Amr S Soliman; Mehdi Karkouri; Meaghen Quinlan-Davidson; Ashley Strahley; Mohab Eissa; Subhojit Dey; Ahmed Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Noureddine Benjaafar; Kathy Toy; Sofia D Merajver
Journal:  Breast Dis       Date:  2011

Review 2.  An updated review of epidemiology, risk factors, and management of male breast cancer.

Authors:  Noman Ahmed Jang Khan; Maria Tirona
Journal:  Med Oncol       Date:  2021-03-15       Impact factor: 3.064

Review 3.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.

Authors:  M R Meyer; D J Clegg; E R Prossnitz; M Barton
Journal:  Acta Physiol (Oxf)       Date:  2011-02-01       Impact factor: 6.311

4.  Validity and Reliability of Turkish Male Breast Self-Examination Instrument.

Authors:  Özüm Erkin; İlknur Göl
Journal:  Eur J Breast Health       Date:  2018-02-15

5.  Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis.

Authors:  Chun-Jiang Li; Yue Dai; Yan-Jun Fu; Jia-Ming Tian; Jin-Lun Li; Hong-Jun Lu; Feng Duan; Qing-Wang Li
Journal:  Tumour Biol       Date:  2014-04-16

Review 6.  Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.

Authors:  Marieke A Vollebergh; Jos Jonkers; Sabine C Linn
Journal:  Cell Mol Life Sci       Date:  2011-09-16       Impact factor: 9.261

Review 7.  Male Breast Cancer.

Authors:  Metin Yalaza; Aydın İnan; Mikdat Bozer
Journal:  J Breast Health       Date:  2016-01-01

8.  Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients.

Authors:  Samuel F Gilbert; Amr S Soliman; Maria Iniesta; Mohab Eissa; Ahmed Hablas; Ibrahim A Seifeldin; Ashley Strahley; Mousumi Banerjee; Sofia D Merajver
Journal:  Breast Cancer Res Treat       Date:  2011-04-20       Impact factor: 4.872

9.  An international comparison of male and female breast cancer incidence rates.

Authors:  Diana Ly; David Forman; Jacques Ferlay; Louise A Brinton; Michael B Cook
Journal:  Int J Cancer       Date:  2012-10-12       Impact factor: 7.396

10.  Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans.

Authors:  Sanjeeve Balasubramaniam; Elaine Ron; Gloria Gridley; Arthur B Schneider; Alina V Brenner
Journal:  J Clin Endocrinol Metab       Date:  2012-05-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.